|Related Categories||Bioactive Small Molecules, Biochemicals and Reagents, Cell Biology, Cell Signaling and Neuroscience, Ether Lipid Metabolism,|
Intermediate in the synthesis of platelet activating factor (PAF). Inactive form that can be used as a control in studies of PAF activity.
Customers Also Viewed
Metabolism of platelet-activating factor by rat alveolar macrophages: lyso-PAF as an obligatory intermediate in the formation of alkylarachidonoyl glycerophosphocholine species. Robinson, M.,and Snyder, F. Biochim. Biophys. Acta 837, 52, (1985)
Sturk, A., et al. J. Lipid Res. 23, 219, (1989)
Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart. Mickelson JK, Simpson PJ, and Lucchesi BR J. Mol. Cell. Cardiol. 20(6), 547-61, (1988)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Need larger quantities for your development, manufacturing or research applications?